Randolph Community College has been selected as one of seven community colleges statewide to participate in a project to redesign how math in taught to reflect how math is applied ...

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.

Rockland Community College (RCC) has started construction on a new $3 million Nursing Simulation Lab on its campus at 145 College Road ...

The trial enrolled 1,841 patients and measured DFS, with safety, OS, and quality of life as secondary endpoints.

Rogue Community College (RCC) is making strides in transportation technology education. The Board of Education approved ...

Randolph Community College officials reflected on the college’s accomplishments and discussed plans for its future at its recent annual spring convocation. Shah Ardalan, RCC president and CEO, ...

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Using the best medication available in the frontline setting of RCC leads to optimal results. David Braun, MD, of the Yale School of Medicine explores the strategic tension between immediate, ...

Randolph Community College’s Automotive Systems Technology program is accelerating into the future of transportation through a $180,000 grant and partnership with N.C. Agricultural and Technical State ...

Adjuvant therapy with durvalumab (Imfinzi) and tremelimumab-actl (Imjudo) in patients with resected RCC was associated with early reductions in patient-reported quality of life (QoL), according to ...

Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is crucial for treatment planning. Systemic therapies, including combination ...

The 2026 GU ASCO annual meeting featured a renal cell carcinoma session and a discussant presentation by Dr. Beckermann, discussing three abstracts, “Belzutifan + lenvatinib versus cabozantinib for ...